New hope for cooling cancer treatment's fiery side effect
NCT ID NCT06617455
Summary
This study tested whether fezolinetant could reduce hot flashes and night sweats in breast cancer patients taking hormone-blocking therapy. These side effects are common and bothersome for patients on these cancer-preventing medications. The trial compared the drug against a placebo to see if it improved symptom frequency, severity, and sleep quality.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANATOMIC STAGE III BREAST CANCER AJCC V8 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Michigan Rogel Cancer Center
Ann Arbor, Michigan, 48109, United States
Conditions
Explore the condition pages connected to this study.